Article
Oncology
Ruige Sun, Chunli Chen, Xinzhou Deng, Fengqin Wang, Shimao Song, Qiang Cai, Jincheng Wang, Te Zhang, Mingliang Shi, Qing Ke, Zhiguo Luo
Summary: IL-11 is upregulated in cervical cancer tissues and associated with clinical stages and poor prognosis. Knocking down IL-11 can reduce radioresistance in Hela cells, while exogeneous IL-11 can confer radioresistance in C33A cells, potentially through the activation of the PI3K/Akt signaling pathway. Therefore, IL-11 may be a promising target for radiosensitization in cervical cancer therapy.
Article
Biochemistry & Molecular Biology
Hannah Murray, Beiying Qiu, Sze Yuan Ho, Xiaomeng Wang
Summary: CFB is a crucial catalytic element in the alternative pathway of complement, playing a key role in ocular angiogenesis by promoting blood vessel formation through mediating the VEGF signaling pathway. This study provides compelling evidence for the involvement of CFB in driving ocular neovascularization in a VEGF-dependent manner, suggesting potential therapeutic targets for blinding eye diseases characterized by pathological angiogenesis.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Medicine, Research & Experimental
Enni Chen, Jiajia Huang, Miao Chen, Jiawei Wu, Puyun Ouyang, Xiaonan Wang, Dingbo Shi, Zhiqiao Liu, Wancui Zhu, Haohui Sun, Shanshan Yang, Baoyu Zhang, Wuguo Deng, Huijuan Qiu, Fangyun Xie
Summary: This study reveals that FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma (NPC) through the TIE1-mediated PI3K/AKT signaling pathway, suggesting that targeting the FLI1/TIE1 signaling pathway could be a potential therapeutic strategy to enhance the efficacy of radiotherapy in NPC.
JOURNAL OF TRANSLATIONAL MEDICINE
(2023)
Article
Biochemistry & Molecular Biology
Yueyue Zhu, Fan Wu, Jianing Hu, Yichi Xu, Jinwen Zhang, Yan Li, Yi Lin, Xiaorui Liu
Summary: Dysregulated trophoblast function, specifically related to lactate dehydrogenase A (LDHA) and the PI3K/AKT/FOXO1/CyclinD1 signaling pathway, may be involved in the development of pregnancy-associated complications such as unexplained recurrent spontaneous abortion (URSA). In this study, the authors found that reduced LDHA levels in the placental villus of URSA patients contributed to G0/G1 phase arrest and increased apoptosis in trophoblast cells. Furthermore, LDHA knockdown affected the phosphorylation levels of PI3K, AKT, and FOXO1, resulting in downregulation of CyclinD1. The findings highlight a novel regulatory pathway for trophoblast cell cycle and proliferation.
Article
Multidisciplinary Sciences
Zhipeng Meng, Fu-Long Li, Cao Fang, Benjamin Yeoman, Yunjiang Qiu, Ying Wang, Xiaomin Cai, Kimberly C. Lin, Di Yang, Min Luo, Vivian Fu, Xiaoxiao Ma, Yarui Diao, Filippo G. Giancotti, Bing Ren, Adam J. Engler, Kun-Liang Guan
Summary: This study reveals that class 3 Semaphorins (SEMA3s) activate the Hippo pathway to regulate tissue growth, angiogenesis, and tumorigenesis, highlighting the critical role of Hippo signaling in SEMA3 physiological function.
Article
Oncology
Xiaoqin Fan, Xina Xie, Ming Yang, Yujie Wang, Hanwei Wu, Tingting Deng, Xin Weng, Weiping Wen, Guohui Nie
Summary: This study revealed the significant role of YBX3 in the metastasis of nasopharyngeal carcinoma, showing that it inhibits epithelial-to-mesenchymal transition and MMP1 activation by regulating the PI3K/AKT signaling pathway. These findings suggest that YBX3 could be a potential therapeutic target for patients with NPC.
FRONTIERS IN ONCOLOGY
(2021)
Article
Oncology
Yu Zhang, Jingjing Xiang, Ni Zhu, Hangping Ge, Xianfu Sheng, Shu Deng, Junfa Chen, Lihong Yu, Yan Zhou, Jianping Shen
Summary: The combination of HHT and curcumin showed significant inhibitory effects on the proliferation, migration, and invasion of lymphoma cells, as well as the secretion of VEGF. Additionally, the combination treatment inhibited the VEGF/Akt signaling pathway, affecting the growth and angiogenesis of lymphoma cells and endothelial cells. These results suggest that HHT combined with curcumin may be a promising therapeutic approach for lymphoma treatment.
FRONTIERS IN ONCOLOGY
(2021)
Editorial Material
Neurosciences
Mohammad Rafi Khezri, Morteza Ghasemnejad-Berenji, Donya Moloodsouri
Summary: One of the main players in apoptosis during Alzheimer's disease progression are different members of caspase family of proteases, with caspase-3 being the most well-known. The PI3K/AKT signaling pathway is the most important intracellular factor involved in regulating caspase-3 activity. This commentary aims to highlight the possible relations between the PI3K/AKT signaling pathway and caspase-3 in Alzheimer's disease.
JOURNAL OF ALZHEIMERS DISEASE
(2023)
Article
Agronomy
Er-Tao Li, Han-Jia Wu, Zhi-Min Wang, Ke-Bin Li, Shuai Zhang, Ya-Zhong Cao, Jiao Yin
Summary: Through RNA sequencing, it was found that the PI3K/Akt/CncC pathway mediates the defense response of H. parallela larvae against EPN-Bt infection, and the expression of CarE18 is associated with this pathway. These findings provide valuable insights for the design of appropriate management strategies to combat this agricultural pest.
PEST MANAGEMENT SCIENCE
(2023)
Article
Biochemistry & Molecular Biology
Lingli Sun, Shuai Wen, Qiuhua Li, Xingfei Lai, Ruohong Chen, Zhenbiao Zhang, Junxi Cao, Shili Sun
Summary: This study found that Theaflavin-3,3'-digallate (TF-3) inhibits prostate cancer cell proliferation by regulating the PKC delta/aSMase signaling pathway. The anti-prostate cancer effect of TF-3 is attributed to the expression of the 67 kDa laminin receptor (67LR).
Review
Biochemistry & Molecular Biology
Yu-Chieh Su, Wei-Chang Lee, Chih-Chun Wang, Shyh-An Yeh, Wen-Hui Chen, Po-Jen Chen
Summary: This review discusses the oncogenic significance of PI3K/AKT/mTOR signaling in HNSCC radiotherapy resistance and highlights the therapeutic potential of small molecule inhibitors against this pathway for radiosensitization in HNSCC treatment. It provides a mechanistic framework for the development of new drugs for radiosensitization in HNSCC radiotherapy via targeting the PI3K/AKT/mTOR signaling pathway.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Oncology
Jeeho Kim, Ho Jin You, Chakyung Youn
Summary: This study confirmed the abnormal decrease of SCARA3 in lung cancer, and overexpression of SCARA3 strongly inhibited tumor growth in lung cancer and induced apoptosis by increasing sensitivity of lung cancer cells to cisplatin.
Article
Medicine, Research & Experimental
Bin Zeng, Xiaoting Liao, Lei Liu, Caixia Zhang, Huaiyu Ruan, Bo Yang
Summary: The study found that T3 pretreatment significantly reduces myocardial infarct area, inhibits cardiomyocyte apoptosis and fibrosis, and improves left ventricular function post-MI. Furthermore, T3 can also promote angiogenesis, reduce inflammatory cytokines, and protect the heart from damage after MI.
Review
Biochemistry & Molecular Biology
Silviu Stanciu, Florentina Ionita-Radu, Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga
Summary: Pancreatic cancer, although relatively rare, is becoming a leading cause of cancer death. Various risk factors, both modifiable and non-modifiable, contribute to its pathogenesis. Chronic inflammation plays a crucial role in the development of pancreatic cancer. The PI3K/AKT/mTOR signaling pathway is important in cell growth, survival, and motility.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Multidisciplinary Sciences
Akihito Ishikita, Shouji Matsushima, Soichiro Ikeda, Kosuke Okabe, Ryohei Nishimura, Tomonori Tadokoro, Nobuyuki Enzan, Taishi Yamamoto, Masashi Sada, Yoshitomo Tsutsui, Ryo Miyake, Masataka Ikeda, Tomomi Ide, Shintaro Kinugawa, Hiroyuki Tsutsui
Summary: The molecular mechanisms of cardiac hypertrophy induced by glucose metabolism remain incompletely understood. The Hexosamine biosynthesis pathway (HBP) plays a key role in mediating cardiac hypertrophy through protein O-GlcNAcylation and Akt activation. GFAT2, a critical enzyme in the HBP pathway, is identified as a major isoform in the heart and is involved in regulating cardiomyocyte hypertrophy.
Article
Cell Biology
Sijia He, Jin Cheng, Lianhui Sun, Yiwei Wang, Chuangui Wang, Xinjian Liu, Zhengxiang Zhang, Minghui Zhao, Yuntao Luo, Ling Tian, Chuanyuan Li, Qian Huang
CELL DEATH & DISEASE
(2018)
Article
Oncology
Jin Cheng, Ling Tian, Jingjing Ma, Yanping Gong, Zhengxiang Zhang, Zhiwei Chen, Bing Xu, Hui Xiong, Chuanyuan Li, Qian Huang
MOLECULAR ONCOLOGY
(2015)
Article
Oncology
Jianzhu Xie, Zheng Ruan, Jian Zheng, Yanping Gong, Yulan Wang, Binjie Hu, Jin Cheng, Qian Huang
Summary: This study found that CRCs have potential advantages in discriminating between malignant and benign SPNs, with high sensitivity and specificity, and could serve as a potential indicator for lung cancer screening in high-risk populations.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
(2022)
Article
Oncology
Sijia He, Qi Li, Qian Huang, Jin Cheng
Summary: This review systematically summarizes the current findings on the architecture, activity regulation and biological functions of protein kinase C (PKC) isoforms, with a focus on their relationship with anti-cancer therapy-induced cell death. Additionally, it elaborates on the effects of PKCs on tumor metabolism and microenvironment, and highlights their implications as a target for cancer therapy.
Article
Oncology
Binjie Hu, Yanping Gong, Yulan Wang, Jianzhu Xie, Jin Cheng, Qian Huang
Summary: This study successfully detected and presented highly heterogeneous circulating rare cells (CRCs) in clinical practice, providing a comprehensive understanding of CRC subtypes and aneuploid chromosomes. The findings have potential contributions to disease diagnosis and therapeutic target cell discovery.
FRONTIERS IN ONCOLOGY
(2022)
Review
Immunology
Sijia He, Qian Huang, Jin Cheng
Summary: Cancer cells can evade cell death and obtain unlimited replication and immortality, which hinders the body from clearing them effectively. Furthermore, evidence suggests that dying tumor cells caused by treatment may even promote cancer progression. Therefore, it is crucial to understand the mechanisms that influence the immune system during cancer treatment to improve outcomes. This review focuses on cell death modes, the relationship between dying tumor cells and tumor immune microenvironment, and emerging limitations and future directions in immunotherapy.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Oncology
Ru-Yi Zhao, Si-Jia He, Jing-Jing Ma, Hai Hu, Yan-Ping Gong, Yu-Lan Wang, Bin-Jie Hu, Jian-Zhu Xie, Wen-Zhi Tu, Qian Huang, Jin Cheng
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
(2018)